Search

everythinglearnresearchcommunity

for

Search:↓

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Women with PCOS have more emotional and body image issues than healthy women.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Hodgkin's lymphoma can show up as hair loss.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Spironolactone plus finasteride works better for treating hirsutism.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.